Systemic Sclerosis Flashcards

1
Q

Systemic sclerosis is interchangeable with which term?

A

Scleroderma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Scleroderma translates directly to?

A

Hardening of the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is systemic sclerosis?

A

an autoimmune inflammatory and fibrotic connective tissue disease. The cause of the condition is unclear. It most notably affects the skin in all areas but it also affects the internal organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 main patterns of disease in systemic sclerosis?

A

Limited cutaneous systemic sclerosis

Diffuse cutaneous systemic sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the features of Limited Cutaneous Systemic Sclerosis?

A

Limited cutaneous systemic sclerosis is the more limited version of systemic sclerosis. It used to be called CREST syndrome. This forms a helpful mnemonic for remembering the features of limited cutaneous systemic sclerosis:

C – Calcinosis
R – Raynaud’s phenomenon
E – oEsophageal dysmotility
S – Sclerodactyly
T – Telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the features of Diffuse Cutaneous Systemic Sclerosis?

A

Diffuse cutaneous systemic sclerosis includes the features of CREST syndrome plus many internal organs causing:

Cardiovascular problems, particularly hypertension and coronary artery disease.

Lung problems, particularly pulmonary hypertension and pulmonary fibrosis.

Kidney problems, particularly glomerulonephritis and a condition called scleroderma renal crisis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is scleroderma?

A

Hardening of the skin

This gives a the appearance of shiny, tight skin without the normal folds in the skin. These changes are most notable on the hands and face.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Sclerodactyly?

A

describes the skin changes in the hands

As the skin tightens around joints it restricts the range of motion in the joint and reduces the function of the joints. As the skin hardens and tightens further the fat pads on the fingers are lost. The skin can break and ulcerate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Telangiectasia?

A

dilated small blood vessels in the skin

They are tiny veins that have dilated

They have a fine, thready appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Calcinosis?

A

Where calcium deposits build up under the skin

This is most commonly found on the fingertips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Raynaud’s phenomenon?

A

where the fingertips go completely white and then blue in response to even mild cold

It is caused by vasoconstriction of the vessels supplying the fingers, this commonly occurs without any associated disease, however it is a classical feature of systemic sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oesophageal dysmotility?

A

caused by connective tissue dysfunction in the oesophagus

This is commonly associated with swallowing difficulties, acid reflex and oesophagitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Systemic and pulmonary hypertension is caused by?

A

connective tissue dysfunction in the systemic and pulmonary arterial systems

Systemic hypertension can be worsened by renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pulmonary fibrosis?

A

can occur in severe systemic sclerosis

This presents with gradual onset dry cough and shortness of breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is Scleroderma renal crisis ?

A

an acute condition where there is a combination of severe hypertension and renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Autoantibodies involved with Systemic Sclerosis?

A

many & helpful in predicting the extent of disease and which organs will be affected

Antinuclear antibodies (ANA) are positive in most patients with systemic sclerosis. They are not specific to systemic sclerosis.

Anti-centromere antibodies are most associated with limited cutaneous systemic sclerosis.

Anti-Scl-70 antibodies are most associated with diffuse cutaneous systemic sclerosis. They are associated with more severe disease.

17
Q

What is Nailfold Capillaroscopy used for?

A

This is a technique where the area where the skin meets the fingernails at the base of the fingernail (the nailfold) is magnified and examined.

This allows us to examine the health of the peripheral capillaries. Abnormal capillaries, avascular areas and micro-haemorrhages indicate systemic sclerosis.

It is useful to support a diagnosis of systemic sclerosis and to investigate patients with Raynaud’s phenomenon to exclude systemic sclerosis.

Patients with primary Raynaud’s without systemic sclerosis will have normal nailfold capillaries.

18
Q

Diagnosis of Systemic Sclerosis?

A

Diagnosis is based on classification criteria from the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) published in 2013.

This involves meeting a number of criteria for clinical features, antibodies and nailfold capillaroscopy.

19
Q

Non-medical management of Systemic Sclerosis involves?

A

Avoid smoking

Gentle skin stretching to maintain the range of motion

Regular emollients

Avoiding cold triggers for Raynaud’s

Physiotherapy to maintain healthy joints

Occupational therapy for adaptations to daily living to cope with limitations

20
Q

Medical management of Systemic Sclerosis?

A

Nifedipine can be used to treat symptoms of Raynaud’s phenomenon

Anti acid medications (e.g. PPIs) and pro-motility medications (e.g. metoclopramide) for gastrointestinal symptoms

Analgesia for joint pain

Antibiotics for skin infections

Antihypertensives can be used to treat
hypertension (usually ACE inhibitors)

Treatment of pulmonary artery hypertension

Supportive management of pulmonary fibrosis